{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:50:19Z","timestamp":1790286619684,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["International Graduate School of Science and Engineering (IGSSE), GSC 81"],"award-info":[{"award-number":["International Graduate School of Science and Engineering (IGSSE), GSC 81"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010345","name":"B. Braun foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010345","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Type 2 diabetes mellitus (T2DM) patients show a markedly higher fracture risk and impaired fracture healing when compared to non-diabetic patients. However in contrast to type 1 diabetes mellitus, bone mineral density in T2DM is known to be normal or even regionally elevated, also known as diabetic bone disease. Charcot arthropathy is a severe and challenging complication leading to bone destruction and mutilating bone deformities. Wnt signaling is involved in increasing bone mineral density, bone homeostasis and apoptotic processes. It has been shown that type 2 diabetes mellitus is strongly associated with gene variants of the Wnt signaling pathway, specifically polymorphisms of TCF7L2 (transcription factor 7 like 2), which is an effector transcription factor of this pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Bone samples of 19 T2DM patients and 7 T2DM patients with additional Charcot arthropathy were compared to 19 non-diabetic controls. qPCR analysis for selected members of the Wnt-signaling pathway (WNT3A, WNT5A, catenin beta, TCF7L2) and bone gamma-carboxyglutamate (BGLAP, Osteocalcin) was performed and analyzed using the 2-\u0394\u0394Ct- Method. Statistical analysis comprised one-way analysis of variance (ANOVA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In T2DM patients who had developed Charcot arthropathy WNT3A and WNT5A gene expression was down-regulated by 89 and 58% compared to healthy controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). TCF7L2 gene expression showed a significant reduction by 63% (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) and 18% (<jats:italic>p<\/jats:italic>\u2009=\u20090.0136) in diabetic Charcot arthropathy. In all diabetic patients BGLAP (Osteocalcin) was significantly decreased by at least 59% (<jats:italic>p<\/jats:italic>\u2009=\u20090.0019).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For the first time with this study downregulation of members of the Wnt-signaling pathway has been shown in the bone of diabetic patients with and without Charcot arthropathy. This may serve as future therapeutic target for this severe disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-022-05314-9","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T13:02:53Z","timestamp":1650286973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dysregulation of Wnt signaling in bone of type 2 diabetes mellitus and diabetic Charcot arthropathy"],"prefix":"10.1186","volume":"23","author":[{"given":"Laurens Christian","family":"Gassel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo J\u00f6rg","family":"Banke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Friedrich","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Volkering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Zeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer Hans Hermann","family":"Burgkart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"von Eisenhart-Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Biberthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Tobias","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"5314_CR1","volume-title":"National Diabetes Statistics Report: estimates of Diabetes and its burden in the United States","author":"Prevention CfdCa","year":"2014","unstructured":"Prevention CfdCa. National Diabetes Statistics Report: estimates of Diabetes and its burden in the United States. Atlanta: US Department of Health and Humans Services; 2014."},{"issue":"1","key":"5314_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","volume":"86","author":"AV Schwartz","year":"2001","unstructured":"Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, et al. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab. 2001;86(1):32\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5314_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporosis Int. 2007;18(4):427\u201344.","journal-title":"Osteoporosis Int"},{"issue":"8","key":"5314_CR4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s001250051248","volume":"42","author":"L Forsen","year":"1999","unstructured":"Forsen L, Meyer HE, Midthjell K, Edna TH. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag health survey. Diabetologia. 1999;42(8):920\u20135.","journal-title":"Diabetologia"},{"issue":"6","key":"5314_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00223-003-0023-7","volume":"73","author":"AV Schwartz","year":"2003","unstructured":"Schwartz AV. Diabetes mellitus: does it affect bone? Calcif Tissue Int. 2003;73(6):515\u20139.","journal-title":"Calcif Tissue Int"},{"key":"5314_CR6","doi-asserted-by":"publisher","unstructured":"Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, et al. The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update. Bone. 2020;137:115457. https:\/\/doi.org\/10.1016\/j.bone.2020.115457. Epub 2020 May 29.","DOI":"10.1016\/j.bone.2020.115457"},{"issue":"7","key":"5314_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1600-0501.2010.01923.x","volume":"21","author":"M Retzepi","year":"2010","unstructured":"Retzepi M, Donos N. The effect of diabetes mellitus on osseous healing. Clin Oral Implants Res. 2010;21(7):673\u201381.","journal-title":"Clin Oral Implants Res"},{"key":"5314_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bone.2017.01.037","volume":"97","author":"M Osima","year":"2017","unstructured":"Osima M, Kral R, Borgen TT, Hogestol IK, Joakimsen RM, Eriksen EF, et al. Women with type 2 diabetes mellitus have lower cortical porosity of the proximal femoral shaft using low-resolution CT than nondiabetic women, and increasing glucose is associated with reduced cortical porosity. Bone. 2017;97:252\u201360.","journal-title":"Bone"},{"issue":"12","key":"5314_CR9","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1210\/jc.2008-0639","volume":"93","author":"LJ Melton 3rd","year":"2008","unstructured":"Melton LJ 3rd, Riggs BL, Leibson CL, Achenbach SJ, Camp JJ, Bouxsein ML, et al. A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab. 2008;93(12):4804\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"5314_CR10","volume":"144","author":"EA Chantelau","year":"2014","unstructured":"Chantelau EA, Grutzner G. Is the Eichenholtz classification still valid for the diabetic Charcot foot? Swiss Med Wkly. 2014;144:w13948.","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"5314_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4239\/wjd.v2.i5.59","volume":"2","author":"E Gouveri","year":"2011","unstructured":"Gouveri E, Papanas N. Charcot osteoarthropathy in diabetes: a brief review with an emphasis on clinical practice. World J Diabetes. 2011;2(5):59\u201365.","journal-title":"World J Diabetes"},{"issue":"6","key":"5314_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/dme.12754","volume":"32","author":"WJ Jeffcoate","year":"2015","unstructured":"Jeffcoate WJ. Charcot foot syndrome. Diabet Med. 2015;32(6):760\u201370.","journal-title":"Diabet Med"},{"issue":"9","key":"5314_CR13","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"LC Rogers","year":"2011","unstructured":"Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"5314_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng1732","volume":"38","author":"SF Grant","year":"2006","unstructured":"Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38(3):320\u20133.","journal-title":"Nat Genet"},{"issue":"1","key":"5314_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2045-3701-2-28","volume":"2","author":"W Ip","year":"2012","unstructured":"Ip W, Chiang YT, Jin T. The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: the current understanding, dispute, and perspective. Cell Biosci. 2012;2(1):28.","journal-title":"Cell Biosci"},{"issue":"8","key":"5314_CR16","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1172\/JCI30706","volume":"117","author":"V Lyssenko","year":"2007","unstructured":"Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007;117(8):2155\u201363.","journal-title":"J Clin Invest"},{"issue":"3","key":"5314_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa062418","volume":"355","author":"JC Florez","year":"2006","unstructured":"Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes prevention program. N Engl J Med. 2006;355(3):241\u201350.","journal-title":"N Engl J Med"},{"issue":"10","key":"5314_CR18","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.cellsig.2008.04.014","volume":"20","author":"T Jin","year":"2008","unstructured":"Jin T, George Fantus I, Sun J. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin. Cell Signal. 2008;20(10):1697\u2013704.","journal-title":"Cell Signal"},{"issue":"16","key":"5314_CR19","doi-asserted-by":"publisher","first-page":"11230","DOI":"10.1074\/jbc.M113.544999","volume":"289","author":"Y Geng","year":"2014","unstructured":"Geng Y, Ju Y, Ren F, Qiu Y, Tomita Y, Tomoeda M, et al. Insulin receptor substrate 1\/2 (IRS1\/2) regulates Wnt\/beta-catenin signaling through blocking autophagic degradation of dishevelled2. J Biol Chem. 2014;289(16):11230\u201341.","journal-title":"J Biol Chem"},{"issue":"6","key":"5314_CR20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1359\/jbmr.060316","volume":"21","author":"NH Kulkarni","year":"2006","unstructured":"Kulkarni NH, Onyia JE, Zeng Q, Tian X, Liu M, Halladay DL, et al. Orally bioavailable GSK-3alpha\/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res. 2006;21(6):910\u201320.","journal-title":"J Bone Miner Res"},{"issue":"48","key":"5314_CR21","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1073\/pnas.0505259102","volume":"102","author":"P Clement-Lacroix","year":"2005","unstructured":"Clement-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssiere B, Belleville C, et al. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci U S A. 2005;102(48):17406\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"5314_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.devcel.2005.03.016","volume":"8","author":"TF Day","year":"2005","unstructured":"Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt\/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005;8(5):739\u201350.","journal-title":"Dev Cell"},{"issue":"6","key":"5314_CR23","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/jcb.20599","volume":"96","author":"PV Bodine","year":"2005","unstructured":"Bodine PV, Billiard J, Moran RA, Ponce-de-Leon H, McLarney S, Mangine A, et al. The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J Cell Biochem. 2005;96(6):1212\u201330.","journal-title":"J Cell Biochem"},{"issue":"2","key":"5314_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/cr.2008.13","volume":"18","author":"PV Bodine","year":"2008","unstructured":"Bodine PV. Wnt signaling control of bone cell apoptosis. Cell Res. 2008;18(2):248\u201353.","journal-title":"Cell Res"},{"issue":"20","key":"5314_CR25","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002;346(20):1513\u201321.","journal-title":"N Engl J Med"},{"key":"5314_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bone.2015.05.046","volume":"82","author":"ML Zoch","year":"2016","unstructured":"Zoch ML, Clemens TL, Riddle RC. New insights into the biology of osteocalcin. Bone. 2016;82:42\u20139.","journal-title":"Bone"},{"issue":"2","key":"5314_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142(2):296\u2013308.","journal-title":"Cell"},{"issue":"11","key":"5314_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188264","volume":"12","author":"A Sebastian","year":"2017","unstructured":"Sebastian A, Hum NR, Murugesh DK, Hatsell S, Economides AN, Loots GG. Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts. PLoS One. 2017;12(11):e0188264.","journal-title":"PLoS One"},{"key":"5314_CR29","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1038\/srep04493","volume":"4","author":"M Okamoto","year":"2014","unstructured":"Okamoto M, Udagawa N, Uehara S, Maeda K, Yamashita T, Nakamichi Y, et al. Noncanonical Wnt5a enhances Wnt\/beta-catenin signaling during osteoblastogenesis. Sci Rep. 2014;4:4493.","journal-title":"Sci Rep"},{"issue":"50","key":"5314_CR30","doi-asserted-by":"publisher","first-page":"41342","DOI":"10.1074\/jbc.M502168200","volume":"280","author":"M Almeida","year":"2005","unstructured":"Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src\/ERK and phosphatidylinositol 3-kinase\/AKT. J Biol Chem. 2005;280(50):41342\u201351.","journal-title":"J Biol Chem"},{"issue":"7","key":"5314_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1055\/s-0034-1366278","volume":"122","author":"W Kerner","year":"2014","unstructured":"Kerner W, Bruckel J, German Diabetes A. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014;122(7):384\u20136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"5314_CR32","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s11999-014-4059-y","volume":"473","author":"AJ Rosenbaum","year":"2015","unstructured":"Rosenbaum AJ, DiPreta JA. Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res. 2015;473(3):1168\u201371.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"5314_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"5","key":"5314_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00423-014-1188-4","volume":"399","author":"AT Haug","year":"2014","unstructured":"Haug AT, Braun KF, Ehnert S, Mayer L, Stockle U, Nussler AK, et al. Gene expression changes in cancellous bone of type 2 diabetics: a biomolecular basis for diabetic bone disease. Langenbeck's Arch Surg. 2014;399(5):639\u201347.","journal-title":"Langenbeck's Arch Surg"},{"issue":"1","key":"5314_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1479164113510923","volume":"11","author":"A Gaudio","year":"2014","unstructured":"Gaudio A, Privitera F, Pulvirenti I, Canzonieri E, Rapisarda R, Fiore CE. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Diab Vasc Dis Res. 2014;11(1):48\u201352.","journal-title":"Diab Vasc Dis Res"},{"issue":"4","key":"5314_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/17453674.2015.1033606","volume":"86","author":"A Folestad","year":"2015","unstructured":"Folestad A, Alund M, Asteberg S, Fowelin J, Aurell Y, Gothlin J, et al. Role of Wnt\/beta-catenin and RANKL\/OPG in bone healing of diabetic Charcot arthropathy patients. Acta Orthop. 2015;86(4):415\u201325.","journal-title":"Acta Orthop"},{"issue":"12","key":"5314_CR37","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41374-020-0451-2","volume":"100","author":"C Yang","year":"2020","unstructured":"Yang C, Wang C, Zhou J, Liang Q, He F, Li F, et al. Fibronectin 1 activates WNT\/beta-catenin signaling to induce osteogenic differentiation via integrin beta1 interaction. Lab Investig. 2020;100(12):1494\u2013502.","journal-title":"Lab Investig"},{"issue":"8","key":"5314_CR38","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1128\/MCB.19.8.5576","volume":"19","author":"D Gradl","year":"1999","unstructured":"Gradl D, Kuhl M, Wedlich D. The Wnt\/Wg signal transducer beta-catenin controls fibronectin expression. Mol Cell Biol. 1999;19(8):5576\u201387.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"5314_CR39","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.bone.2009.02.012","volume":"44","author":"SW Cho","year":"2009","unstructured":"Cho SW, Yang JY, Sun HJ, Jung JY, Her SJ, Cho HY, et al. Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells. Bone. 2009;44(6):1069\u201377.","journal-title":"Bone"},{"issue":"10","key":"5314_CR40","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.2337\/db06-0474","volume":"55","author":"S Cauchi","year":"2006","unstructured":"Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes. 2006;55(10):2903\u20138.","journal-title":"Diabetes"},{"issue":"3","key":"5314_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1210\/me.2009-0379","volume":"24","author":"TL McCarthy","year":"2010","unstructured":"McCarthy TL, Centrella M. Novel links among Wnt and TGF-beta signaling and Runx2. Mol Endocrinol. 2010;24(3):587\u201397.","journal-title":"Mol Endocrinol"},{"issue":"39","key":"5314_CR42","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.M500608200","volume":"280","author":"T Gaur","year":"2005","unstructured":"Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 2005;280(39):33132\u201340.","journal-title":"J Biol Chem"},{"issue":"13","key":"5314_CR43","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1073\/pnas.0711119105","volume":"105","author":"M Ferron","year":"2008","unstructured":"Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105(13):5266\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"5314_CR44","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1359\/jbmr.081234","volume":"24","author":"JM Kindblom","year":"2009","unstructured":"Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009;24(5):785\u201391.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"5314_CR45","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/jcp.24278","volume":"228","author":"A Neve","year":"2013","unstructured":"Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol. 2013;228(6):1149\u201353.","journal-title":"J Cell Physiol"},{"issue":"3","key":"5314_CR46","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130(3):456\u201369.","journal-title":"Cell"},{"issue":"6","key":"5314_CR47","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1053\/j.jfas.2018.03.023","volume":"57","author":"JC Connors","year":"2018","unstructured":"Connors JC, Hardy MA, Kishman LL, Botek GG, Verdin CJ, Rao NM, et al. Charcot pathogenesis: a study of in vivo gene expression. J Foot Ankle Surg. 2018;57(6):1067\u201372.","journal-title":"J Foot Ankle Surg"},{"issue":"1","key":"5314_CR48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41598-017-00563-4","volume":"7","author":"B Bruhn-Olszewska","year":"2017","unstructured":"Bruhn-Olszewska B, Korzon-Burakowska A, Wegrzyn G, Jakobkiewicz-Banecka J. Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development. Sci Rep. 2017;7(1):501.","journal-title":"Sci Rep"},{"issue":"6","key":"5314_CR49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cmet.2005.11.011","volume":"2","author":"BF Boyce","year":"2005","unstructured":"Boyce BF, Xing L, Chen D. Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling. Cell Metab. 2005;2(6):344\u20135.","journal-title":"Cell Metab"},{"issue":"6","key":"5314_CR50","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.devcel.2005.10.009","volume":"9","author":"M Kieslinger","year":"2005","unstructured":"Kieslinger M, Folberth S, Dobreva G, Dorn T, Croci L, Erben R, et al. EBF2 regulates osteoblast-dependent differentiation of osteoclasts. Dev Cell. 2005;9(6):757\u201367.","journal-title":"Dev Cell"},{"issue":"3","key":"5314_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00774-010-0222-z","volume":"29","author":"M Mikasa","year":"2011","unstructured":"Mikasa M, Rokutanda S, Komori H, Ito K, Tsang YS, Date Y, et al. Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation. J Bone Miner Metab. 2011;29(3):291\u20139.","journal-title":"J Bone Miner Metab"},{"key":"5314_CR52","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1471-2164-10-365","volume":"10","author":"M Gry","year":"2009","unstructured":"Gry M, Rimini R, Stromberg S, Asplund A, Ponten F, Uhlen M, et al. Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics. 2009;10:365.","journal-title":"BMC Genomics"},{"issue":"2","key":"5314_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000216","volume":"2","author":"N Fu","year":"2007","unstructured":"Fu N, Drinnenberg I, Kelso J, Wu JR, Paabo S, Zeng R, et al. Comparison of protein and mRNA expression evolution in humans and chimpanzees. PLoS One. 2007;2(2):e216.","journal-title":"PLoS One"},{"issue":"3","key":"5314_CR54","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1158\/1535-7163.MCT-06-0650","volume":"6","author":"UT Shankavaram","year":"2007","unstructured":"Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK, et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther. 2007;6(3):820\u201332.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"5314_CR55","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","volume":"4","author":"D Greenbaum","year":"2003","unstructured":"Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 2003;4(9):117.","journal-title":"Genome Biol"},{"issue":"1","key":"5314_CR56","doi-asserted-by":"publisher","first-page":"16450","DOI":"10.1038\/s41598-017-16365-7","volume":"7","author":"J Pasquier","year":"2017","unstructured":"Pasquier J, Thomas B, Hoarau-Vechot J, Odeh T, Robay A, Chidiac O, et al. Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction. Sci Rep. 2017;7(1):16450.","journal-title":"Sci Rep"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05314-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-022-05314-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05314-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T17:07:39Z","timestamp":1650388059000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-022-05314-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5314"],"URL":"https:\/\/doi.org\/10.1186\/s12891-022-05314-9","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"22 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. A positive vote of the ethics committee of the Technical University of Munich was obtained (No. 5579\/12). Written informed consent of the patients was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. van Griensven reports grants from B. Braun Foundation, during the conduct of the study; personal fees from Bone Support, personal fees from Bone Therapeutics, personal fees from Osteopharma, outside the submitted work. Other authors have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}